Increase in Research Fundings Generating Growth Prospects in the Global miRNA Market

Reportstack has announced a new market research report on the Global miRNA Market 2015-2019, which is expected to post a CAGR of 13.36 percent during the forecast period of 2014-2019. The Global miRNA market is influenced by growing awareness about the potential of miRNA in the diagnostics and therapy of diseases such as cancer, which has led to an increase in the discovery and development of miRNA-based diagnostics products and therapeutics by several leading pharmaceutical companies. A large number of miRNA vendors have introduced new and advanced tools and reagents to support miRNA-based research and diagnostics and therapeutics development.

“The immense diagnostic and therapeutic potential of miRNA-based solutions have attracted research institutes, big pharmaceutical companies, and governments of various countries to focus on miRNA research,”.

“There are a number of researches in progress that aim to explore the application of miRNA-based therapeutics as an effective treatment for serious diseases.”

Key Market Drivers

  • Increased Investment in miRNA-based Research and Drug Development
  • Increase in Prevalence of Chronic Diseases
  • Advances in Technology
  • Increased miRNA Research Funding

Key Market Trends

  • Increased M&A
  • Growth of Bioinformatics Software and Services Sector
  • Increased Strategic Collaborations and Licensing Activities

Key Market Vendors

  • Affymetrix Inc.
  • Agilent Technologies Inc.
  • Exiqon A/S
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.

To define the market circumstances in the next 3-4 years, the analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.

Complete report with TOC available @ Increase in Research Fundings Generating Growth Prospects in the Global miRNA Market.